Early upfront plerixafor administration on day 3 in the "chemo-free" mobilization regimen G-CSF plus Plerixafor, for Multiple Myeloma patients: a retrospective single center experience

被引：0
|
作者：
Bozzoli, Valentina [1 ]
Mazzotta, Paola [1 ]
Matera, Rosella [1 ]
Messa, Anna Rita [1 ]
Dargenio, Michelina [1 ]
Canaris, Donato [2 ]
Di Renzo, Nicola [1 ]
机构：
[1] Osped Vito Fazzi, Dept Hematol, Lecce, Italy
[2] Osped Vito Fazzi, Serv Med Trasfus & Immunoematol, Lecce, Italy
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P836
引用
收藏
页码：769 / 769
页数：1
相关论文
共 50 条
  • [1] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    Afifi, S.
    Adel, N. G.
    Devlin, S.
    Duck, E.
    Vanak, J.
    Landau, H.
    Chung, D. J.
    Lendvai, N.
    Lesokhin, A.
    Korde, N.
    Reich, L.
    Landgren, O.
    Giralt, S.
    Hassoun, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 546 - 552
  • [2] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    S Afifi
    N G Adel
    S Devlin
    E Duck
    J Vanak
    H Landau
    D J Chung
    N Lendvai
    A Lesokhin
    N Korde
    L Reich
    O Landgren
    S Giralt
    H Hassoun
    Bone Marrow Transplantation, 2016, 51 : 546 - 552
  • [3] Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Nazha, Aziz
    Cook, Rachel
    Vogl, Dan T.
    Mangan, Patricia A.
    Hummel, Kimberly
    Cunningham, Kathleen
    Luger, Selina
    Porter, David
    Schuster, Stephen J.
    O'Doherty, Una
    Sell, Mary
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 844 - 844
  • [4] A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis
    Laszlo, D.
    Marcacci, GP.
    Martino, M.
    Radice, D.
    Rabascio, C.
    Lucchetti, B.
    Magaro, A.
    Caime, A.
    Menna, S.
    Lionetti, MT.
    Bertolini, F.
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (05)
  • [5] Despite Use of Upfront Plerixafor and G-CSF, Daratumumab Exposure Reduces Stem Cell Mobilization in Patients with Multiple Myeloma
    Edmisson, Jacob
    Fiala, Mark A.
    Slade, Michael J.
    Vickroy, Angela
    Kavanaugh, Margaret
    Wilson, Carmen
    Xiang, Jingyu
    Crees, Zachary D.
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    DiPersio, John F.
    Vij, Ravi
    BLOOD, 2022, 140 : 4295 - 4296
  • [6] Upfront Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: An Update on Cost Analysis Study at Memorial Sloan Kettering Cancer Center
    Afifi, Salma
    Adel, Nelly G.
    Duck, Elaine
    Devlin, Sean M.
    Landau, Heather
    Lendvai, Nikoletta
    Lesokhin, Alexander M.
    Chung, David J.
    Landgren, Ola
    Giralt, Sergio A.
    Hassoun, Hani
    BLOOD, 2014, 124 (21)
  • [7] Effect of plerixafor plus G-CSF on tumour cell mobilisation in patients with multiple myeloma
    Fruehauf, S.
    Topaly, J.
    Muller, S.
    Moos, M.
    Goldschmidt, H.
    Ho, A. D.
    Calandra, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S146 - S146
  • [8] A Comparison of Chemotherapy plus G-CSF Versus Plerixafor (Mazobil®) plus G-CSF for Stem Cell Mobilization In Patients with Multiple Myeloma Treated with Lenalidomide.
    Mark, Tomer M.
    Rossi, Adriana C.
    Pearse, Roger N.
    Coleman, Morton
    Bernstein, David
    Zafar, Faiza
    Dergis, Usama
    Shore, Tsiporah B.
    Niesvizky, Ruben
    BLOOD, 2010, 116 (21) : 928 - 929
  • [9] Autologous Stem Cell Mobilization in AL Amyloidosis with Plerixafor and G-CSF: Update of a Single Center Experience
    Kaul, Esha
    Shah, Gunjan L.
    Chaulagain, Chakra
    Comenzo, Raymond
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S113 - S114
  • [10] G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis
    Antar, Ahmad
    Otrock, Zaher
    Kharfan-Dabaja, Mohamed
    Abou Ghaddara, Hussein
    Kreidieh, Nabila
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
12345